LSERS
CHRS icon

Louisiana State Employees Retirement System’s Coherus Oncology CHRS Stock Holding History

Louisiana State Employees Retirement System’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-35,100
Closed -$150K – 1524
2023
Q2 		$150K Buy
35,100
+5,000
+17% +$29.5K ﹤0.01% 1516
2023
Q1 		$206K Sell
30,100
-600
-2% -$4.66K 0.01% 1472
2022
Q4 		$243K Sell
30,700
-100
-0.3% -$769 0.01% 1441
2022
Q3 		$296K Sell
30,800
-300
-1% -$3.04K 0.01% 1384
2022
Q2 		$237K Buy
31,100
+100
+0.3% +$870 0.01% 1458
2022
Q1 		$313K Buy
31,000
+100
+0.3% +$1.27K 0.01% 1430
2021
Q4 		$493K Buy
30,900
+300
+1% +$5.25K 0.01% 1314
2021
Q3 		$492K Buy
30,600
+500
+2% +$7.33K 0.01% 1307
2021
Q2 		$416K Buy
30,100
+1,000
+3% +$14.2K 0.01% 1349
2021
Q1 		$425K Sell
29,100
-100
-0.3% -$1.7K 0.01% 1329
2020
Q4 		$507K Buy
29,200
+100
+0.3% +$1.78K 0.01% 1164
2020
Q3 		$534K Buy
29,100
+12,500
+75% +$233K 0.02% 936
2020
Q2 		$296K Buy
+16,600
New +$281K 0.02% 1060

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Louisiana State Employees Retirement System's CHRS Position: Q3 2023 in Review

Louisiana State Employees Retirement System sold out of Coherus Oncology (CHRS) in Q3 2023, closing a stake of 35,100 shares — an estimated $150K sold.

Louisiana State Employees Retirement System first reported a position in CHRS in Q2 2020 and held it in 13 quarters. The position peaked at $534K in Q3 2020. 169 funds tracked by Wall St. Rank hold CHRS as of Q3 2023.

  • Louisiana State Employees Retirement System reported no remaining Coherus Oncology position as of Q3 2023 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 35,100 Coherus Oncology shares in Q3 2023, an estimated $150K.
  • Louisiana State Employees Retirement System first reported a position in Coherus Oncology in Q2 2020 and held it in 13 quarters.
  • Louisiana State Employees Retirement System's Coherus Oncology position peaked at $534K in Q3 2020.
  • 169 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2023.

Based on Louisiana State Employees Retirement System's 13F filing for Q3 2023, filed 17 Oct 2023.